These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18470911)

  • 21. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
    El-Tanani MK; Jin D; Campbell FC; Johnston PG
    Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells.
    DeWald DB; Torabinejad J; Samant RS; Johnston D; Erin N; Shope JC; Xie Y; Welch DR
    Cancer Res; 2005 Feb; 65(3):713-7. PubMed ID: 15705865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
    Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
    Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells.
    Sheng XJ; Zhou DM; Liu Q; Lou SY; Song QY; Zhou YQ
    Eur J Gynaecol Oncol; 2014; 35(3):236-42. PubMed ID: 24984534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
    Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
    Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: lack of correlation with metastasis to axillary lymph nodes.
    Kelly LM; Buggy Y; Hill A; O'Donovan N; Duggan C; McDermott EW; O'Higgins NJ; Young L; Duffy MJ
    Tumour Biol; 2005; 26(4):213-6. PubMed ID: 16006775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.
    Kong B; Lv ZD; Wang Y; Jin LY; Ding L; Yang ZC
    Int J Clin Exp Pathol; 2015; 8(9):11076-83. PubMed ID: 26617826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression.
    Champine PJ; Michaelson J; Weimer BC; Welch DR; DeWald DB
    Clin Exp Metastasis; 2007; 24(7):551-65. PubMed ID: 17896182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
    Schulze EB; Hedley BD; Goodale D; Postenka CO; Al-Katib W; Tuck AB; Chambers AF; Allan AL
    Breast Cancer Res Treat; 2008 Nov; 112(2):243-54. PubMed ID: 18097747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
    Wang ZM; Cui YH; Li W; Chen SY; Liu TS
    Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
    Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
    BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.
    Kim B; Nam HJ; Pyo KE; Jang MJ; Kim IS; Kim D; Boo K; Lee SH; Yoon JB; Baek SH; Kim JH
    Biochem Biophys Res Commun; 2011 Dec; 415(4):720-6. PubMed ID: 22085717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression.
    Hurst DR; Xie Y; Thomas JW; Liu J; Edmonds MD; Stewart MD; Welch DR
    PLoS One; 2013; 8(2):e55966. PubMed ID: 23390556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression.
    Edmonds MD; Hurst DR; Vaidya KS; Stafford LJ; Chen D; Welch DR
    Int J Cancer; 2009 Oct; 125(8):1778-85. PubMed ID: 19585508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [DNA methylation modification of BRMS1 in triple-negative breast cancer and its correlation with tumor metastasis].
    Xia J; Lü ZD; Zhou PH; Cui SC; Kong B; Liu D; Long SS; Zhang XH; Zhao JJ
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(44):3483-3487. PubMed ID: 29275584
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1.
    Shevde LA; Samant RS; Goldberg SF; Sikaneta T; Alessandrini A; Donahue HJ; Mauger DT; Welch DR
    Exp Cell Res; 2002 Feb; 273(2):229-39. PubMed ID: 11822878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells.
    Kapoor P; Saunders MM; Li Z; Zhou Z; Sheaffer N; Kunze EL; Samant RS; Welch DR; Donahue HJ
    Int J Cancer; 2004 Sep; 111(5):693-7. PubMed ID: 15252837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
    Shevde LA; Samant RS; Paik JC; Metge BJ; Chambers AF; Casey G; Frost AR; Welch DR
    Clin Exp Metastasis; 2006; 23(2):123-33. PubMed ID: 16830223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo].
    Jiang J; Xia M; Feng JB; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):398-402. PubMed ID: 17697602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.